West Pharmaceutical Services, Inc. - stock earnings

WST Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
April 25, 2024 BeforeMarket 657.1 million 670.3 million 676.6 million

WST Quarterly earnings

DateEarningsRevenue
2023Q4 137.0 million USD 732.0 million USD
2023Q3 161.3 million USD 747.4 million USD
2023Q2 155.1 million USD 753.8 million USD
2023Q1 140.0 million USD 716.6 million USD
2022Q4 103.0 million USD 708.7 million USD
2022Q3 120.6 million USD 686.9 million USD
2022Q2 188.5 million USD 771.3 million USD
2022Q1 173.8 million USD 720.0 million USD
2021Q4 147.7 million USD 730.8 million USD
2021Q3 175.6 million USD 706.5 million USD
2021Q2 187.3 million USD 723.6 million USD
2021Q1 151.2 million USD 670.7 million USD
2020Q4 98.4 million USD 580.2 million USD
2020Q3 82.3 million USD 548.0 million USD
2020Q2 91.2 million USD 527.2 million USD
2020Q1 74.3 million USD 491.5 million USD
2019Q4 63.9 million USD 470.6 million USD
2019Q3 56.3 million USD 456.1 million USD
2019Q2 66.1 million USD 469.7 million USD
2019Q1 55.4 million USD 443.5 million USD
2018Q4 52.0 million USD 422.5 million USD
2018Q3 55.2 million USD 431.7 million USD
2018Q2 56.1 million USD 447.5 million USD
2018Q1 43.6 million USD 415.7 million USD
2017Q4 -2.5 million USD 415.6 million USD
2017Q3 51.0 million USD 398.2 million USD
2017Q2 38.8 million USD 397.6 million USD
2017Q1 60.9 million USD 387.7 million USD
2016Q4 39.1 million USD 382.3 million USD
2016Q3 37.6 million USD 376.7 million USD
2016Q2 44.7 million USD 388.0 million USD
2016Q1 22.1 million USD 362.1 million USD
2015Q4 33.4 million USD 359.7 million USD
2015Q3 1.5 million USD 344.5 million USD
2015Q2 27.8 million USD 359.7 million USD
2015Q1 32.9 million USD 335.9 million USD
2014Q4 31.4 million USD 349.8 million USD
2014Q3 31.0 million USD 355.9 million USD
2014Q2 37.6 million USD 368.9 million USD
2014Q1 27.1 million USD 346.8 million USD
2013Q4 23.6 million USD 342.7 million USD
2013Q3 26.8 million USD 341.8 million USD
2013Q2 30.2 million USD 344.5 million USD
2013Q1 31.7 million USD 339.4 million USD
2012Q4 21.1 million USD 321.5 million USD
2012Q3 14.8 million USD 303.8 million USD
2012Q2 15.6 million USD 324.8 million USD
2012Q1 29.2 million USD 316.3 million USD
2011Q4 18.8 million USD 295.4 million USD
2011Q3 16.9 million USD 293.6 million USD
2011Q2 20.1 million USD 307.9 million USD
2011Q1 19.6 million USD 295.4 million USD
2010Q4 6.0 million USD 276.8 million USD
2010Q3 17.8 million USD 271.4 million USD
2010Q2 21.7 million USD 281.8 million USD
2010Q1 19.8 million USD 274.7 million USD
2009Q4 20.3 million USD 293.4 million USD
2009Q3 17.2 million USD 258.9 million USD
2009Q2 19.7 million USD 261.0 million USD
2009Q1 15.4 million USD 242.4 million USD
2008Q4 17.7 million USD 244.8 million USD
2008Q3 13.3 million USD 256.2 million USD
2008Q2 28.7 million USD 279.3 million USD
2008Q1 26.2 million USD 270.7 million USD
2007Q4 6.0 million USD 256.1 million USD
2007Q3 12.2 million USD 242.7 million USD
2007Q2 26.0 million USD 263.7 million USD
2007Q1 26.5 million USD 257.6 million USD
2006Q4 15.0 million USD 231.9 million USD
2006Q3 13.3 million USD 218.4 million USD
2006Q2 20.7 million USD 240.2 million USD
2006Q1 18.1 million USD 222.8 million USD
2005Q4 11.7 million USD 195.7 million USD
2005Q3 7.8 million USD 181.6 million USD
2005Q2 12.8 million USD 173.0 million USD
2005Q1 13.3 million USD 149.5 million USD
2004Q4 400000 USD 134.6 million USD
2004Q3 4.3 million USD 135.3 million USD
2004Q2 7.7 million USD 138.1 million USD
2004Q1 7.0 million USD 133.6 million USD
2003Q4 17.1 million USD 126.4 million USD
2003Q3 4.1 million USD 120.1 million USD
2003Q2 6.9 million USD 126.4 million USD
2003Q1 3.8 million USD 117.8 million USD
2002Q4 3.4 million USD 103.4 million USD
2002Q3 3.6 million USD 104.9 million USD
2002Q2 5.3 million USD 107.7 million USD
2002Q1 6.1 million USD 103.7 million USD
2001Q4 -19.6 million USD 50.6 million USD
2001Q3 5.9 million USD 112.9 million USD
2001Q2 3.1 million USD 117.2 million USD
2001Q1 5.4 million USD 116.2 million USD
2000Q4 -13.1 million USD 105.2 million USD
2000Q3 4.6 million USD 104.5 million USD
2000Q2 5.0 million USD 112.7 million USD
2000Q1 5.1 million USD 107.7 million USD
1999Q4 10.2 million USD 115.4 million USD
1999Q3 8.6 million USD 115.1 million USD
1999Q2 10.4 million USD 124.4 million USD
1999Q1 10.0 million USD 114.8 million USD
1998Q4 10.0 million USD 114.8 million USD
1998Q3 6.5 million USD 113.9 million USD
1998Q2 9.9 million USD 115.8 million USD
1998Q1 8.6 million USD 109.5 million USD
1997Q4 8.6 million USD 109.5 million USD
1997Q3 17.3 million USD 105.2 million USD
1997Q2 10.1 million USD 123.1 million USD
1997Q1 8.4 million USD 114.7 million USD
1996Q4 9.9 million USD 114.6 million USD
1996Q3 6.6 million USD 111.3 million USD
1996Q2 8.1 million USD 119.0 million USD
1996Q1 -8.2 million USD 113.9 million USD
1995Q4 7.9 million USD 107.6 million USD
1995Q3 3.9 million USD 101.1 million USD
1995Q2 8.7 million USD 109.0 million USD
1995Q1 8.2 million USD 95.2 million USD
1994Q4 7.2 million USD 99.1 million USD
1994Q3 5.6 million USD 87.4 million USD
1994Q2 7.5 million USD 91.5 million USD
1994Q1 7.0 million USD 87.1 million USD
1993Q4 5.9 million USD 92.8 million USD
1993Q3 4.8 million USD 81.9 million USD
1993Q2 6.2 million USD 87.1 million USD
1993Q1 6.6 million USD 86.9 million USD
1992Q4 4.4 million USD 88.4 million USD
1992Q3 4.1 million USD 81.3 million USD
1992Q2 5.6 million USD 86.7 million USD
1992Q1 5.6 million USD 81.8 million USD
1991Q4 -18.5 million USD 82.2 million USD
1991Q3 2.3 million USD 79.6 million USD
1991Q2 3.5 million USD 81.8 million USD
1991Q1 4.1 million USD 86.1 million USD
1990Q4 -5.9 million USD 80.4 million USD
1990Q3 1.7 million USD 76.9 million USD
1990Q2 2.9 million USD 82.1 million USD
1990Q1 5.6 million USD 83.8 million USD
1989Q4 ? USD 79.7 million USD
1989Q3 ? USD 69.4 million USD
1989Q2 ? USD 79.5 million USD
1989Q1 ? USD 80.1 million USD
1988Q4 ? USD 75.4 million USD
1988Q3 ? USD 69.0 million USD
1988Q2 ? USD 74.5 million USD
1988Q1 ? USD 69.3 million USD
1987Q4 ? USD 66.5 million USD
1987Q3 ? USD 57.0 million USD
1987Q2 ? USD 67.9 million USD
1987Q1 ? USD 61.9 million USD
1986Q4 ? USD 61.1 million USD
1986Q3 ? USD 57.0 million USD
1986Q2 ? USD 64.3 million USD
1986Q1 ? USD 53.2 million USD
1985Q4 ? USD 47.7 million USD
1985Q3 ? USD 42.7 million USD

WST Yearly earnings

DateEarningsRevenue
2023 593.4 million USD 2.9 billion USD
2022 585.9 million USD 2.9 billion USD
2021 661.8 million USD 2.8 billion USD
2020 346.2 million USD 2.1 billion USD
2019 241.7 million USD 1.8 billion USD
2018 206.9 million USD 1.7 billion USD
2017 150.7 million USD 1.6 billion USD
2016 143.6 million USD 1.5 billion USD
2015 95.6 million USD 1.4 billion USD
2014 127.1 million USD 1.4 billion USD
2013 112.3 million USD 1.4 billion USD
2012 80.7 million USD 1.3 billion USD
2011 75.5 million USD 1.2 billion USD
2010 65.3 million USD 1.1 billion USD
2009 72.6 million USD 1.1 billion USD
2008 86.0 million USD 1.1 billion USD
2007 70.7 million USD 1.0 billion USD
2006 67.1 million USD 913.3 million USD
2005 45.6 million USD 699.7 million USD
2004 19.4 million USD 541.6 million USD
2003 31.9 million USD 490.7 million USD
2002 18.4 million USD 419.7 million USD
2001 -5.2 million USD 396.9 million USD
2000 1.6 million USD 430.1 million USD
1999 38.7 million USD 469.1 million USD
1998 6.7 million USD 449.7 million USD
1997 44.4 million USD 452.5 million USD
1996 16.4 million USD 458.8 million USD
1995 28.7 million USD 412.9 million USD
1994 27.3 million USD 365.1 million USD
1993 23.5 million USD 348.7 million USD
1992 19.7 million USD 338.2 million USD
1991 -8.5 million USD 329.6 million USD
1990 4.3 million USD 323.2 million USD
1989 20.7 million USD 308.7 million USD
1988 17.4 million USD 288.2 million USD
1987 13.7 million USD 253.3 million USD
1986 17.0 million USD 235.6 million USD
1985 15.0 million USD 190.1 million USD

WST

List: Champions

Price: 395.71USD

52 week price:
264.02
415.73

Dividend Yield: 0.22%

5-year range yield:
0.17%
0.57%

Forward Dividend Yield: 0.20%

Payout Ratio: 10.75%

Payout Ratio Range:
7.47%
95.16%

Dividend Per Share: 0.80 USD

Earnings Per Share: 7.44 USD

P/E Ratio: 53.53

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 800100

Ebitda: 85.9 million

Market Capitalization: 26.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 40

DGR3: 5.57%

DGR5: 5.92%

DGR10: 6.69%

DGR20: 6.45%

Links: